Skip to main content

ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection.

Publication ,  Preprint
Semmes, EC; Miller, IG; Rodgers, N; Phan, CT; Hurst, JH; Walsh, KM; Stanton, RJ; Pollara, J; Permar, SR
March 17, 2023

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

DOI

Publication Date

March 17, 2023
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Semmes, E. C., Miller, I. G., Rodgers, N., Phan, C. T., Hurst, J. H., Walsh, K. M., … Permar, S. R. (2023). ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection. https://doi.org/10.1101/2023.03.15.23287332
Semmes, Eleanor C., Itzayana G. Miller, Nicole Rodgers, Caroline T. Phan, Jillian H. Hurst, Kyle M. Walsh, Richard J. Stanton, Justin Pollara, and Sallie R. Permar. “ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection.,” March 17, 2023. https://doi.org/10.1101/2023.03.15.23287332.
Semmes EC, Miller IG, Rodgers N, Phan CT, Hurst JH, Walsh KM, et al. ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection. 2023.
Semmes, Eleanor C., et al. ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection. 17 Mar. 2023. Pubmed, doi:10.1101/2023.03.15.23287332.
Semmes EC, Miller IG, Rodgers N, Phan CT, Hurst JH, Walsh KM, Stanton RJ, Pollara J, Permar SR. ADCC-activating antibodies correlate with protection against congenital human cytomegalovirus infection. 2023.

DOI

Publication Date

March 17, 2023